<DOC>
	<DOCNO>NCT02356146</DOCNO>
	<brief_summary>Tacrolimus dose highly varies among Asian kidney transplant recipient . This explain variety CYP3A5 expression . CYP3A5 genotyping highly recommended patient receive tacrolimus . Here , assess tacrolimus dose prediction compare CYP3A5 expression tacrolimus dosage use tacrolimus concentration single dose administration prior kidney transplantation . Plasma tacrolimus trough level measure 12 hour first dose 0.1 mg/kg tacrolimus ( TacC12 ) , orally administer 51 new kidney transplant recipient . Patients CYP3A5 inhibitor/inducer co-medications exclude . Genotyping CYP3A5 expression carry RT-PCR . The dosage tacrolimus post-operative day 7 dosage provide stable therapeutic level post-operative month 1 3 ( C0 5-8 ng/mL ) record . The genotyping , TacC12 , target tacrolimus dosage good correlation .</brief_summary>
	<brief_title>First Tacrolimus Dose Trough Level Better Than CYP3A5 Genotyping Tacrolimus Dose Prediction</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>All KT recipient Recipient receive tacrolimus</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Kidney transplantation</keyword>
	<keyword>genotype</keyword>
	<keyword>tacrolimus</keyword>
	<keyword>CYP3A5</keyword>
</DOC>